Skip to main content
SpringerLink
Log in

Yin-yang and Zheng: Exported from Chinese medicine

  • Feature Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Chinese medicine (CM) basic theory differs substantially from modern medicine in methodology. CM views the healthy human body as an entity in yinyang equilibrium. CM practitioners typically diagnose patients with “Zheng (CM syndrome)”-yin-yang status of specific organs, and the ultimate goal of treatment in CM is to restore the yin-yang balance. This concept might seem strange to Western perceptions; however, CM philosophy and methodology have been gradually accepted and used in the West. There is growing evidence from prestigious worldwide journals like Nature, Science and Cell indicating that CM theory is becoming an important component in dealing with health issues in the West.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cheung F. TCM: Made in China. Nature 2011;480:S82–S83.

    Article  PubMed  CAS  Google Scholar 

  2. Man PL, Chen A. Acupuncture analgesia for the treatment of trigeminal neuralgias. A series of forty-one cases. Dis Nervous System 1974;35:520–522.

    CAS  Google Scholar 

  3. Bonica JJ. Acupuncture anesthesia in the People’s Republic of China implications for American medicine. JAMA 1974;229:1317–1325.

    Article  PubMed  CAS  Google Scholar 

  4. Wang Z, Xu Y, Liao J. Experimental study on apoptosis of HL-60 cell induced by arsenic trioxide. Chin J Integr Tradit West Med (Chin) 2000;20:536–538.

    CAS  Google Scholar 

  5. Hu X, Ma L, Hu N. Ailing No. I in treating 62 cases of acute promyelocytic leukemia. Chin J Integr Tradit West Med (Chin) 1999;19:473–476.

    CAS  Google Scholar 

  6. Wang Z, Ma R, Zheng J. Clinical and experimental study on the treatment of myelodysplastic syndromes with Fuzheng Quxie Tablet. Chin J Integr Tradit West Med (Chin) 1999;19:664–667.

    CAS  Google Scholar 

  7. Yanada M, Tsuzuki M, Fujita H, Fujimaki K, Fujisawa S, Sunami K, et al. Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia. Blood 2013;121:3095–3102.

    Article  PubMed  CAS  Google Scholar 

  8. Grimm SA, Marymont M, Chandler JP, Muro K, Newman SB, Levy RM, et al. Phase I study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant gliomas. J Neuro-oncology 2012;110:237–243.

    Article  CAS  Google Scholar 

  9. Wu J, Henderson C, Feun L, Van Veldhuizen P, Gold P, Zheng H, et al. Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma. Inv New Drugs 2010;28:670–676.

    Article  CAS  Google Scholar 

  10. Tu Y. The development of new antimalarial drugs: qinghaosu and dihydro-qinghaosu. Chin Med J 1999;112:976–977.

    PubMed  CAS  Google Scholar 

  11. TU You-you won Lasker Debakey clinical medical research award—for her outstanding achievements in studies on artemisinin. Chin J Integr Tradit West Med (Chin) 2011;31:1301.

  12. Deng Z, Cao P, Wan MM, Sui G, Yin Y. A multifaceted protein beyond a transcription factor. Transcription 2010;1:81–84.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Bonavida B, Jazirehi A, Vega MI, Huerta-Yepez S, Baritaki S. Roles each of snail, yin yang 1 and RKIP in the regulation of tumor cells chemo-immuno-resistance to apoptosis. Forum Immunopathol Dis Ther 2013;4:1–14.

    Article  Google Scholar 

  14. Nogueiras R, Tschop M. Biomedicine: separation of conjoined hormones yields appetite rivals. Science 2005;310:985–986.

    Article  PubMed  CAS  Google Scholar 

  15. Dillin A, Kelly JW. Medicine. The yin-yang of sirtuins. Science 2007;317:461–462.

    Article  PubMed  CAS  Google Scholar 

  16. Mueller K. Inflammation. Inflammation’s yin-yang. Introduction. Science 2013;339:155.

    Article  PubMed  CAS  Google Scholar 

  17. Gallagher R. Tagging T cells: TH 1 or TH2? Science 1997;275:1615.

    Article  PubMed  CAS  Google Scholar 

  18. Awasthi A, Kuchroo VK. Immunology. The yin and yang of follicular helper T cells. Science 2009;325:953–955.

    PubMed  CAS  Google Scholar 

  19. Allison JP, Krummel MF. The Yin and Yang of T cell costimulation. Science 1995;270:932–933.

    Article  PubMed  CAS  Google Scholar 

  20. Miles R. Perspectives: neurobiology. Diversity in inhibition. Science 2011;4:ec193.

    Google Scholar 

  21. Stern PR. Yin and Yang stress responses. Sci Signal 2011;4:ec193.

    Google Scholar 

  22. Ray LB. The Yin and Yang of neuronal maintenance. Sci Signal 2008;1:ec145.

    Google Scholar 

  23. Moore KA, Lemischka IR. Stem cells and their niches. Science 2006;311:1880–1885.

    Article  PubMed  CAS  Google Scholar 

  24. McNiven Ma, Thompson HM. Thompson vesicle formation at the plasma membrane and trans-golgi network. Science 2006;313:1591–1594.

    Article  PubMed  CAS  Google Scholar 

  25. Tan YH. Yin and yang of phosphorylation in cytokine signaling. Science 1993;262:376–377.

    Article  PubMed  CAS  Google Scholar 

  26. Hutt D, Balch WE. Cell biology. The proteome in balance. Science 2010;329:766–767.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  27. Wells L, Vosseller K, Hart GW. Glycosylat ion of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science 2001;291:2376–2378.

    Article  PubMed  CAS  Google Scholar 

  28. Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 1995;80:225–236.

    Article  PubMed  CAS  Google Scholar 

  29. Edgerton DS, Cherrington AD. Glucagon’s yin and yang effects on hepatic glucose production. Nature Med 2013;19:674–675.

    Article  PubMed  CAS  Google Scholar 

  30. Lu B, Pang PT, Woo NH. The yin and yang of neurotrophin action. Nature reviews. Neuroscience 2005;6:603–614.

    PubMed  CAS  Google Scholar 

  31. Yue PY, Mak NK, Cheng YK, Leung KW, Ng TB, Fan DT, et al. Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chin Med 2007;2:1–21.

    Article  CAS  Google Scholar 

  32. Wang WX, Wang W, Chen KJ. Protective effect and mechanism of ginsenosides on central nerve system of animals. Chin J Integr Tradit West Med (Chin) 2005;25:89–93.

    Google Scholar 

  33. Im DS, Nah SY. Yin and Yang of ginseng pharmacology: ginsenosides vs gintonin. Acta Pharmacol Sin 2013;34:1367–1373.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  34. Huber M, Knottnerus JA, Green L, van der Horst H, Jadad AR, Kromhout D, et al. iHow should we define health? BMJ 2011;343:d4163.

    Article  PubMed  Google Scholar 

  35. van der Greef J. Perspective: all systems go. Nature 2011;480:S87.

    Article  PubMed  CAS  Google Scholar 

  36. Zhong LY, Shen ZY, Cai DF. Effect of three kinds (tonifying kidney, invigorating spleen, promoting blood circulation) recipes on the hypothalamus-pituitary-adrenal-thymus (HPAT) axis and CRF gene expression. Chin J Integr Tradit West Med (Chin) 1997;17:39–41.

    CAS  Google Scholar 

  37. Cai D, Chen X, Liu Y. Effect of regulation of kidney-yin and kidney-yang on hypothalamus-pituitary-adrenal-thymus axis in monosodium L-glutamate rats. Chin J Integr Tradit West Med (Chin) 1999;19:415–417.

    CAS  Google Scholar 

  38. Tang XD, Liu F, Li L, Liu C, Zhang SS, Xiao HY, et al. Analysis of the prognostic factors of very severe aplastic anemia treated with Chinese Kidney-invigorating drugs in combination with anti-lymphocyte globulin or anti-thymocyte globulin. Chin J Integr Med 2012;18:40–45.

    Article  PubMed  CAS  Google Scholar 

  39. Li S, Zhang ZQ, Wu LJ, Zhang XG, Li YD, Wang YY. Understanding Zheng in traditional Chinese medicine in the context of neuro-endocrine-immune network. IET Systems Biol 2007;1:51–60.

    Article  Google Scholar 

  40. Smolen JS, Aletaha D. Challenges of predicting treatment response in patients with rheumatoid arthritis. Nat Clin Pract Rheumatol 2005;1:62–63.

    PubMed  Google Scholar 

  41. Rindfleisch JA, Muller D. Diagnosis and management of rheumatoid arthritis. Am Family Phys 2005;72:1037–1047.

    Google Scholar 

  42. van der Greef J, McBurney RN. Innovation: rescuing drug discovery: in vivo systems pathology and systems pharmacology. Nature reviews. Drug Discovery 2005;4:961–967.

    PubMed  Google Scholar 

  43. Glocker MO, Guthke R, Kekow J, Thiesen HJ. Rheumatoid arthritis, a complex multifactorial disease: on the way toward individualized medicine. Med ResRev 2006;26:63–87.

    CAS  Google Scholar 

  44. van Wietmarschen H, Yuan K, Lu C, Gao P, Wang J, Xiao C, et al. Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients. J Clin Rheumatol 2009;15:330–337.

    Article  PubMed  Google Scholar 

  45. Lu C, Zha Q, Chang A, He Y, Lu A. Pattern differentiation in traditional Chinese medicine can help define specific indications for biomedical therapy in the treatment of rheumatoid arthritis. J Altern Complement Med 2009;15:1021–1025.

    Article  PubMed  Google Scholar 

  46. van Wietmarschen HA, Reijmers TH, van der Kooij AJ, Schroen J, Wei H, Hankemeier T, et al. Sub-typing of rheumatic diseases based on a systems diagnosis questionnaire. PloS one 2011;6:e24846.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  47. Gibson G. Wellness and Health Omics linked to the environment: The WHOLE approach to personalized medicine. Adv Exp Med Biol 2014;799:1–14.

    Article  PubMed  Google Scholar 

  48. Yan XF, Ni Q, Wei JP, Lin L. A systematic review and metaanalysis of type 2 diabetes mellitus treatment based on the “three-typed syndrome differentiation” theory in Chinese medicine. Chin J Integr Med 2013;19:1–8.

    Google Scholar 

  49. Wang Z, Oh E, Clapp DW, Chernoff J, Thurmond DC. Inhibition or ablation of p21-activated kinase (PAK1) disrupts glucose homeostatic mechanisms in vivo. J Biolog Chem 2011;286:41359–41367.

    Article  CAS  Google Scholar 

  50. Wang Z, Oh E, Thurmond DC. Glucosestimulated cdc42 signaling is essential for the second phase of insulin secretion. J Biol Chem 2007;282:9536–9546.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  51. Chen YC, Fueger PT, Wang Z. Depletion of PAK1 enhances ubiquitin-mediated Survivin degradation in pancreatic beta-cells. Islets 2013;5:22–28.

    Article  PubMed Central  PubMed  Google Scholar 

  52. Wang Z, Thurmond DC. PAK1 limits the expression of the pro-apoptotic protein Bad in pancreatic islet beta-cells. FEBS Open Bio 2012;2:273–277.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  53. Nie J, Han X, Shi Y. SAD-A and AMPK kinases: The “yin and yang” regulators of mTORC1 signaling in pancreatic beta cells. Cell Cycle 2013;12:3366–3369.

    Article  PubMed  CAS  Google Scholar 

  54. Wang Z, Zhang H. Antidiabetic effects of ginseng in humans and rodents. J Metabolic Synd 2012;1:106.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Indiana University School of Medicine, Indianapolis, Indiana, USA

    Hong-ji Zhang  (张红激)

  2. Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, 46202, USA

    Zhan-xiang Wang  (王展翔)

Authors
  1. Hong-ji Zhang  (张红激)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhan-xiang Wang  (王展翔)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhan-xiang Wang  (王展翔).

Additional information

Partly supported by CTSI-KL2 award to Wang ZX (RR025760) from National Institutes of Health (NIH)/National Center for Research Resources (NCRR)-Indiana Clinical and Translational Sciences Institute (ICTSI)-K12 Program (A.Shekhar)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, Hj., Wang, Zx. Yin-yang and Zheng: Exported from Chinese medicine. Chin. J. Integr. Med. 20, 250–255 (2014). https://doi.org/10.1007/s11655-014-1777-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-014-1777-z

Keywords

Search

Navigation